You are here
As biotech selling spreads, more weakness is seen for US health stocks
AFTER a four-year love affair with healthcare shares, investors are moving on.
Selling has spread from biotechs - shaken on Sept 21 when Hillary Clinton first tweeted concerns about drug prices - to other areas of the healthcare sector. Investors have been dumping shares
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org